Detected ·
Modus Therapeutics
SEK 7.6M—
Modus Therapeutics completed a directed new equity issue of SEK 7.6M to fund development of drug candidate sevuparin through 2027, with investors including Tellus Equity AB and Selandia Alpha Invest A/S.
- Website
- —
- —
- Amount
- kr 7 600 000 SEK
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-05 00:13:19 UTC
- Signal ID
- ddb0efe7-5de2-42ec-99af-b949be58d685
As the API returns it
{
"id": "ddb0efe7-5de2-42ec-99af-b949be58d685",
"created_at": "2026-09-05T00:13:19.779262Z",
"company_name": "Modus Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 7600000,
"funding_currency": "SEK",
"funding_stage": null,
"message": "*Modus Therapeutics completed a directed new equity issue of SEK 7.6M to fund development of drug candidate sevuparin through 2027, with investors including Tellus Equity AB and Selandia Alpha Invest A/S.*"
}